NCT03556267 is a NA clinical trial of spinal needle in Anesthesia, Obestetric, sponsored by Cairo University.

Who is sponsoring NCT03556267?

NCT03556267 is sponsored by Cairo University.

What drugs are being tested in NCT03556267?

Interventions in NCT03556267: spinal needle.

What condition does NCT03556267 study?

NCT03556267 studies Anesthesia, Obestetric.

Is NCT03556267 still recruiting?

NCT03556267 is currently completed. Last updated 16 February 2021.

Last reviewed 2021-02-16 · How we verify

NCT03556267

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Regional Anesthesia of Cesarean Section

Completed NA Last updated 16 February 2021

What this trial tests

NA trial testing spinal needle in Anesthesia, Obestetric in 90 participants. Completed in 14 February 2021.

Timeline

14 August 2019

Primary endpoint
30 October 2020

14 February 2021

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	90
Start date	14 August 2019
Primary completion	30 October 2020
Estimated completion	14 February 2021
Sites	1 location across Egypt

Drugs / interventions tested

spinal needle

Conditions studied

Anesthesia, Obestetric — all drugs for Anesthesia, Obestetric →

Sponsor

Cairo University

Who can join

Adults 18 to 45, female only, with Anesthesia, Obestetric. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Beta trace protein assay is an indicator of post-spinal CSF leak that predicts the degree of post-spinal headache.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03556267 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 16 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03556267.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing